Proton Therapy in Early-Onset Locally Advanced Rectal Cancer: The Importance of Fertility-Preserving Multimodality Care - Report - MDSpire

Proton Therapy in Early-Onset Locally Advanced Rectal Cancer: The Importance of Fertility-Preserving Multimodality Care

  • By

  • April 28, 2026

  • 5 min

Share

Proton Therapy in Early-Onset Locally Advanced Rectal Cancer: The Importance of Fertility-Preserving Multimodality Care

Overview

This report discusses the case of a 37-year-old woman with early-onset locally advanced rectal cancer who underwent proton therapy as part of a fertility-preserving multimodal treatment approach. The findings emphasize the importance of minimizing radiation exposure to reproductive organs in younger patients to mitigate long-term risks such as infertility.

Background

The rising incidence of early-onset colorectal cancer (EOCRC) poses significant challenges for screening and treatment, particularly in younger patients who often present with advanced disease. This demographic shift necessitates a focus on fertility preservation and tailored treatment strategies to improve outcomes and quality of life. Proton therapy offers a promising option due to its dosimetric advantages over conventional radiation methods.

Data Highlights

No numerical data available in the source material.

Key Findings

  • The patient presented with stage III rectal adenocarcinoma, highlighting the trend of advanced disease in younger populations.
  • Proton therapy was chosen for its ability to minimize radiation exposure to non-target pelvic tissues, particularly the ovaries.
  • The treatment was well tolerated, with minimal acute toxicity and no significant long-term treatment-related morbidity reported at follow-up.
  • Fertility preservation was a central consideration, with proton therapy potentially lowering the risks of premature menopause and infertility.
  • Multidisciplinary care is crucial for optimal outcomes in rectal cancer management, especially in younger patients.

Clinical Implications

Clinicians should maintain a high index of suspicion for colorectal cancer in younger patients presenting with relevant symptoms. Timely screening and a multidisciplinary approach are essential for improving outcomes and addressing the unique needs of this population, particularly regarding fertility preservation.

Conclusion

The case underscores the importance of integrating fertility-preserving strategies in the treatment of early-onset locally advanced rectal cancer. Proton therapy represents a valuable option in achieving effective cancer control while minimizing long-term reproductive risks.

References

  1. The ASCO Post, 2014 -- Neoadjuvant Chemotherapy Without Routine Radiotherapy Shows Promise in Patients With Locally Advanced Rectal Cancer
  2. The ASCO Post, 2024 -- Intensity-Modulated Radiation Therapy and Proton-Beam Therapy May Offer Equally High Quality of Life and Tumor Control in Patients With Localized Prostate Cancer
  3. The ASCO Post, 2025 -- ASCO Updates Guideline for Fertility Preservation in People With Cancer
  4. Fast Facts, 2026 -- Colorectal Cancer Statistics
  5. The ASCO Post — Proton Therapy and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer KEY POINTS
  6. the asco post — Proton Therapy and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer
  7. Fast Facts Colorectal Cancer Statistics, 2026 • I
  8. ASCO Updates Guideline for Fertility Preservation in People With Cancer - The ASCO Post
  9. Evaluating the Effectiveness of Proton Beam Therapy Compared to Conventional Radiotherapy in Non-Metastatic Rectal Cancer: A Systematic Review of Clinical Outcomes | MDPI

Original Source(s)

Related Content